Nevertheless, the spontaneous HCC mouse model employed in the study was driven by overexpression of human MET/ΔN90-β-catenin oncogenes, which do not faithfully replicate human HCC initiation and progression. The gene discussed is MET; the disease is hepatocellular carcinoma.